Patents Assigned to Transkaryotic Therapies, Inc.
  • Patent number: 5965125
    Abstract: An implantable device having a body of matrix material made up of insoluble collagen fibrils, and disposed therewithin(a) a plurality of vertebrate cells; and(b) a plurality of microspheres each of which consists primarily of one or more of the following materials: collagen, polystyrene, dextran, polyacrylamide, cellulose, calcium alginate, latex, polysulfone, or glass.
    Type: Grant
    Filed: October 25, 1995
    Date of Patent: October 12, 1999
    Assignee: Transkaryotic Therapies, Inc.
    Inventor: Rochelle Mineau-Hanschke
  • Patent number: 5869239
    Abstract: Materials and methods for homologous-recombination screening of DNA libraries constructed in a eukaryotic host and methods for homologous-recombination chromosome walking for isolating overlapping DNA sequences for building an extended physical map of a chromosomal region.
    Type: Grant
    Filed: May 17, 1995
    Date of Patent: February 9, 1999
    Assignee: Transkaryotic Therapies, Inc.
    Inventors: Douglas A. Treco, Allan M. Miller
  • Patent number: 5817789
    Abstract: Chimeric proteins, which bind a cell surface receptors, useful in transporting a selected substance present in extracellular fluids, such as blood or lymph, into cells; quantitative assays for the selected substance using chimeric proteins; DNA encoding the chimeric proteins; plasmids which contain DNA encoding the chimeric proteins; mammalian cells, modified to contain DNA encoding the chimeric proteins, which express and, optionally, secrete the chimeric proteins; a method of producing the chimeric proteins; a method of isolating the chimeric proteins; a method of using the chimeric proteins to assay the selected substance; and a method of reducing extracellular levels of the selected substance through administration of the chimeric protein, which results in transport of the selected substance into cells.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: October 6, 1998
    Assignee: Transkaryotic Therapies, Inc.
    Inventors: Michael W. Heartlein, Jeffrey F. Lemontt, Michael F. Concino
  • Patent number: 5783385
    Abstract: Materials and methods for homologous-recombination screening of r-DNA libraries constructed in a yeast host and methods for homologous-recombination chromosome walking for isolating overlapping DNA sequences for building an extended physical map of a chromosomal region.
    Type: Grant
    Filed: September 6, 1994
    Date of Patent: July 21, 1998
    Assignee: Transkaryotic Therapies, Inc.
    Inventors: Douglas A. Treco, Allan M. Miller
  • Patent number: 5733761
    Abstract: The present invention relates to transfected primary, secondary and immortalized cells of vertebrate origin, particularly mammalian origin, transfected with exogenous genetic material (DNA) which encodes a desired (e.g., a therapeutic) product or is itself a desired (e.g., therapeutic) product, methods by which primary, secondary and immortalized cells are transfected to include exogenous genetic material, including DNA targeting by homologous recombination, methods for the activation and amplification of endogenous cellular genes, methods by which cells useful for large-scale protein production can be obtained, methods of producing clonal cell strains or heterogenous cell strains, and methods of gene therapy in which transfected primary, secondary or immortalized cells are used.
    Type: Grant
    Filed: May 26, 1995
    Date of Patent: March 31, 1998
    Assignee: Transkaryotic Therapies, Inc.
    Inventors: Douglas Treco, Michael W. Heartlein, Richard F. Selden
  • Patent number: 5733746
    Abstract: The invention relates to novel human DNA sequences, targeting constructs, and methods for producing novel genes encoding thrombopoietin, DNase I, and .beta.-interferon by homologous recombination. The targeting constructs comprise at least: a) a targeting sequence; b) a regulatory sequence; c) an exon; and d) a splice-donor site. The targeting constructs, which can undergo homologous recombination with endogenous cellular sequences to generate a novel gene, are introduced into cells to produce homologously recombinant cells. The homologously recombinant cells are then maintained under conditions which will permit transcription of the novel gene and translation of the mRNA produced, resulting in production of either thrombopoietin, DNase I, or .beta.-interferon. The invention further relates to a methods of producing pharmaceutically useful preparations containing thrombopoietin, DNase I, or .beta.
    Type: Grant
    Filed: March 17, 1995
    Date of Patent: March 31, 1998
    Assignee: Transkaryotic Therapies, Inc.
    Inventors: Douglas A. Treco, Michael W. Heartlein, Brian M. Hauge, Richard F. Selden
  • Patent number: 5641670
    Abstract: The invention relates to constructs comprising: a) a targeting sequence; b) a regulatory sequence; c) an exon; and d) an unpaired splice-donor site. The invention further relates to a method of producing protein in vitro or in vivo comprising the homologous recombination of a construct as described above within a cell. The homologously recombinant cell is then maintained under conditions which will permit transcription and translation, resulting in protein expression. The present invention further relates to homologously recombinant cells, including primary, secondary, or immortalized vertebrate cells, methods of making the cells, methods of homologous recombination to produce fusion genes, methods of altering gene expression in the cells, and methods of making a protein in a cell employing the constructs of the invention.
    Type: Grant
    Filed: May 13, 1994
    Date of Patent: June 24, 1997
    Assignee: Transkaryotic Therapies, Inc.
    Inventors: Douglas A. Treco, Michael W. Heartlein, Richard F. Selden
  • Patent number: 5580734
    Abstract: Materials and methods for homologous-recombination screening of DNA libraries constructed in a eukaryotic host and methods for homologous-recombination chromosome walking for isolating overlapping DNA sequences for building an extended physical map of a chromosomal region.
    Type: Grant
    Filed: September 6, 1994
    Date of Patent: December 3, 1996
    Assignee: Transkaryotic Therapies, Inc.
    Inventors: Douglas A. Treco, Allan M. Miller